Marina Falaleeva Ph.D. has worked as a Scientist at Sangamo Therapeutics since July 2016, supporting next-generation sequencing and PCR based assay development. Dr. Falaleeva received her Ph.D. in molecular biology from the Lomonosov Moscow State University, where she worked on the development of ultrasensitive methods for nucleic acid detection. Prior to joining Sangamo, Dr. Falaleeva worked as a postdoctoral scientist at the University of Kentucky, where she studied the molecular mechanisms of rare genetic disorders.
Monday, November 4
4:30 PM – 5:00 PM